Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed
Drug Channels
Tue, 09/17/19 - 03:35 pm
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Merck's Ebola vaccine tees up FDA date, aiming for first status
Fierce Biotech
Tue, 09/17/19 - 10:16 am
Merck
ebola virus
vaccines
FDA
V920
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Renal Cell Carcinoma Space in Focus: Some Key Developments
Yahoo/Zacks.com
Sat, 09/14/19 - 11:18 am
renal cell carcinoma
kidney cancer
Exelixis
Roche
Merck
Aveo Oncology
Who joins Purdue on pharma's top settlements list? Merck, GSK and Pfizer, for starters
Fierce Pharma
Thu, 09/12/19 - 12:01 pm
Purdue Pharma
legal
Merck
GSK
Pfizer
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
EP Vantage
Tue, 09/10/19 - 11:49 pm
ESMO
Keytruda
Tecentriq
Merck
Roche
WCLC: Merck's Keytruda dispels 'urban legend' with latest lung cancer survival win
Fierce Pharma
Tue, 09/10/19 - 09:30 am
Merck
Keytruda
non-small cell lung cancer
WCLC
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
WCLC
lung cancer
KRAS
AMG 510
Amgen
RET
Merck
Keytruda
AstraZeneca
Imfinzi
Blueprint Medicines
Eli Lilly
WCLC: Merck analyses throw doubt on new biomarker's utility
Fierce Pharma
Mon, 09/9/19 - 09:50 am
Merck
biomarkers
TMB
Keytruda
Keytruda combo cleared as first-line kidney cancer treatment in EU
Pharmaforum
Thu, 09/5/19 - 08:20 pm
Merck
Keytruda
kidney cancer
Europe
Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug
Endpoints
Tue, 09/3/19 - 11:30 pm
Bellus Health
IPOs
chronic cough
Merck
FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
Wed, 08/28/19 - 11:02 pm
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
HHS pledges $23M to develop Merck's experimental Ebola vaccine
Beckers Hospital Review
Fri, 08/23/19 - 10:19 am
HHS
vaccines
Merck
V920
ebola virus
Merck teams up with Themis to develop vaccines
Fierce Biotech
Thu, 08/22/19 - 11:09 am
Merck
vaccines
Themis Bioscience
R&D
Merck’s Keytruda: A Deep Dive
BioSpace
Wed, 08/21/19 - 11:51 pm
Merck
Keytruda
What happened a year ago this week in biopharma? August 12-18, 2018
Mon, 08/19/19 - 11:04 am
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sun, 08/18/19 - 04:30 pm
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals
Investors Business Daily
Sat, 08/17/19 - 01:31 pm
Merck
Keytruda
cancer
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
…
next ›
last »